Similarly, low-dose aspirin is the only anti-platelet drug currently recommended, and only within the first 24–48 h in patients with mild stroke [3], and all anticoagulant/platelet therapy is contraindicated within 24 h of thrombolysis with tissue type plasminogen activator (tPA) [4]. Here, PLAT is linked to Stroke.